基本信息 产品详情 公司简介 推荐产品
网站主页 LY-367385;(R)-(+)-ALPHA-AMINO-4-CARBOXY-2-METHYLBENZENEACETIC ACID 化合物 LY367385
  • 化合物 LY367385|T15818|TargetMol

化合物 LY367385|T15818|TargetMol

LY367385
198419-91-9
4160 10mg 起订
17300 50mg 起订
上海 更新日期:2024-12-12

TargetMol中国(陶术生物)

VIP3年
联系人:邵小姐
手机:4008200310 拨打
邮箱:marketing@tsbiochem.com

产品详情:

中文名称:
化合物 LY367385
英文名称:
LY367385
CAS号:
198419-91-9
品牌:
TargetMol
产地:
美国
保存条件:
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
产品类别:
抑制剂
货号:
T15818

Product Introduction

Bioactivity

名称LY367385
描述LY367385 is a highly effective and selective mGluR1a antagonist. LY367385 has neuroprotective, anticonvulsant, and antiepileptic effects. Compared with > 100 μM for mGlu5a, LY367385 has an IC50 of 8.8 μM for inhibits of quisqualate-induced phosphoinositide (PI) hydrolysis.
体外活性LY367385 shows greater efficacy than LY367366 and neither of these compounds influenced neuronal viability per se and it also displays effective neuroprotective effects, causing a 50% reduction in (S)-3,5-Dihydroxyphenylglycine (DHPG) potentiation at a concentration of 10 nM. LY367385 combined with N-methyl-D-aspartate (NMDA) during the toxic pulse decreases neuronal degeneration in a concentration-dependent fashion, with a maximal reduction of NMDA toxicity ranging from 40 to 60%. LY367385 fully antagonized the amplification of NMDA toxicity by DHPG under experimental conditions at higher concentrations of the antagonist[2].
体内活性LY367385 produces a rapid, transient suppression of sound-induced clonic seizures (ED50 = 12 nM, i.c.v., 5 min), in DBA/2 mice. LY367385 significantly decreases the incidence of spontaneous spike and wave discharges on the electroencephalogram in lethargic mice, from 30 to >150 min after the administration of LY367385, 250 nM, i.c.v. LY367385 has been administered intracerebroventricularly (i.c.v.) to DBA/2 mice and lethargic mice (lh/lh), and focally into the inferior colliculus of genetically epilepsy prone rats (GEPR). LY367385 reduces sound-induced clonic seizures, in genetically epilepsy prone rats. LY367385, 160 nM bilaterally, fully suppresses clonic seizures after 2-4 h[3].
存储条件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
关键字LY-367385 | LY367385 | LY 367385
相关产品Ursodeoxycholic acid sodium | Cilofexor | Hyodeoxycholic acid | Sevelamer hydrochloride | T0901317 | DY268 | Lithocholic acid | GSK2324 | Altenusin | Obeticholic Acid | Forskolin | GW 4064
LY367385|TargetMol

公司简介

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿,致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区,已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库,以及多种类型的生化试剂产品,包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等,此外,我们还建设有CADD(计算机辅助药物设计)研究中心、药理实验室、药化合成平台三大技术中心,全方位满足客户的定制需求。 凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持,我们将有效帮助您缩短研发周期,取得更成功的结果。

成立日期 (12年)
注册资本 566.265100万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 天然产物,生化试剂,分子生物学,分子砌块,生物技术服务

化合物 LY367385相关厂家报价

  • 198419-91-9
  • 198419-91-9
  • 陕西缔都医药化工有限公司 VIP
  • 2025-01-03
  • 询价
内容声明
拨打电话 立即询价